Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Cancer patients are not always aware of cardiotoxicity of treatments

A new study reveals an urgent need to monitor the heart of cancer patients due to the cardiotoxicity of some cancer treatments.

A new study reveals an urgent need to monitor the heart of cancer patients due to the cardiotoxicity of some cancer treatments. The research, presented at EuroHeartCare 2019, a scientific congress of the European Society of Cardiology, found that many physicians are not telling cancer patients about the cardiotoxicity risks of treatments and may not be fully aware of the dangers themselves.  The growing number of cancer survivors and an increasing number of over-65s needing chronic cancer therapy mean that the need for cardio-oncology services is rising. Heart failure caused by cancer therapy can occur up to 20 years after treatment.

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy